logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Galena Biopharma (GALE) Plunges as Concerns over Scandal Continue

By  +Follow February 14, 2014 5:26AM
Share:
Tickers Mentioned:

Share in Galena Biopharma (GALE) plunged nearly 25 percent to begin trading Friday on heavy volume as the fallout from the company’s stock promotion scandal appears to continue. The sell-off appeared to break through a major technical barrier that had developed in recent months, causing the drop to pick up steam as the morning wore on.

GALE Hammered Again on Heavy Volume

Shares of Galena were moving fast on Friday morning as the stock went into freefall soon after the opening bell. Without any specific news appearing to drive the drop, the sell-off appears to be motivated by speculators, residual negative sentiment from Wednesday’s revelations that the company was paying a marketing firm to pump its stock, or some combination of both.

The fall paused briefly at 10 am after the stock reached $4 a share, a price that had been acting as a support level since mid-December. However, after circling the drain for about 15 minutes, the selling resumed and Galena appeared to break through said support level firmly. Shares then kept falling, reaching $3.30 a share before starting to bounce back just after 11 am.

Pipeline Must Produce

The good news for Galena investors is that the company currently has what appears to be a robust product pipeline in place. Oral pain treatment Abstral has already been approved for use in the market and was officially launched in October. However, some Galena shorts estimate that the drug’s 5 percent market share will ultimately only net $20 million to $30 million for Galena.

Meanwhile, the company also has three different drugs currently in various stages of development: NeuVax, GALE-401, and GALE-301, a Folate Binding Protein vaccine for ovarian and endometrial cancer patients. NeuVax is currently in two separate trials to test its efficacy in treating breast cancer (one is testing the drug in combination with Herceptin), with a third trial in planning to test its effect on gastric cancer patients.

Galena’s website describes NeuVax as follows: “NeuVax consists of the E75 peptide derived from HER2 combined with the immune adjuvant granulocyte macrophage colony stimulating factor (GM-CSF).  Treatment with NeuVax stimulates cytotoxic (CD8+) T cells in a highly specific manner to target cells expressing any level of HER2.  NeuVax is given as an intradermal injection once a month for six months, followed by a booster injection once every six months.”

Herceptin, which is only available as a treatment to a quarter of women affected by breast cancer, had revenues of $5 billion in 2010, giving Galena hope that sunnier days are around the corner. However, the recent revelations of stock promotion may place extra pressure on future clinical results for the company.

Noble Financial’s Endorsement Not a Timely One

The plummeting share price for Galena comes just two weeks after Noble Financial reiterated its buy rating on the stock and raised the price target from $4 to $6 a share.

“With improved pk metrics GALE-401 may be more effective without the tolerability/safety issues of Anagrelide-IR; could capture larger market share over HU; US sales potential of $150 to $200M; 8K new cases of ET each year and 80-100K prevalence in US ... Company has discussed with FDA, GALE-401 will be developed under 505b2 path for ET with Anagrelide-IR as reference drug; Phase 2 studies to begin shortly; could be on the market late 2017 or early 2018,” Analyst Rahul Jasuja noted.

Analysts have been kind to Galena in 2014, with two other analysts weighing in on Tuesday, Jan. 21. Maxim Group rated the stock a buy and raised its price target from $9 to $11, while Needham & Company increased their own price target to $9 a share. That makes five different research analysts rating the stock a buy, and the average price target for the company is $7.64 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for GALE
Stock Dawgzz
28 Mar 15 01:25:40
Our Penny Stock Alerts Have Gained Over 1600% In THe Past 4 Months! Subscribe Today: http://t.co/nsMnuzW59n $ETEK $GALE $RSOL
Stock Rocket
28 Mar 15 01:04:04
Our Penny Stock Newsletter Picks Gained Over 1485%! Huge Update: http://t.co/cDuleLERch $ETEK $GALE $RSOL
alexander
27 Mar 15 20:05:42
Commented on StockTwits: no doubut about it... $GALE shitty management caused this stock to become worthless. all... http://t.co/09aLhByzF1
BuyersStrike
27 Mar 15 17:36:36
With everything else going on this week, easy to miss that $GALE obv has been having trouble enrolling patients into its scamvax+hercept p2.
dailystockplays.com
27 Mar 15 14:23:09
RSI Below 30 http://t.co/Cq9Q1m4Sxq $ROVI $DD $GALE $LRCX $MEIP $IDRA $CTIC $DAR $MON $GMCR $ACHN $WTW $HLSS $NKTR $LUK $CMCSK $PPC $FMC
EricWuebben
27 Mar 15 13:12:10
$GALE tripled down
alexander
27 Mar 15 12:52:09
Commented on StockTwits: really ...I love when average high school Joe talks about science of $GALE :-) http://t.co/HJOaFhaXYs
alexander
27 Mar 15 12:17:14
$GALE amazing how many pumpers are still active on this board ....
StockenheimerSchmidt
27 Mar 15 12:07:51
$RCGP Has More Than Tripled In Value In The Past 2 Days! Big News: http://t.co/RWkbY02YnU $ETEK $GALE $RSOL
PennyStocker
27 Mar 15 11:47:41
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $GALE $NTEK $AG $VIP
Keubiko
27 Mar 15 10:39:30
RT @SeekingAlpha: Five Lessons From Ohr Pharma http://t.co/8dUvri6cw2 $CYTR $GALE $ONVO $UNXL $OHRP
Stockaholics
27 Mar 15 10:39:14
Our Stock Tips Have Gained Over 230% In Less Than 24 Hours! Huge News: http://t.co/FW1zCkmOE6 $ETEK $GALE $RSOL
Project B.R.U.C.E.
27 Mar 15 10:29:16
$GALE letssss go
Stock Rocket
27 Mar 15 10:23:17
Our Penny Stock Newsletter Picks Gained Over 1485%! Huge Update: http://t.co/cDuleLngkJ $ETEK $GALE $RSOL
Healthcare Stocks
27 Mar 15 10:22:01
Five Lessons From Ohr Pharma http://t.co/R9nMVTlVlt $CYTR $GALE $ONVO $UNXL $OHRP
Seeking Alpha
27 Mar 15 10:22:01
Five Lessons From Ohr Pharma http://t.co/8dUvri6cw2 $CYTR $GALE $ONVO $UNXL $OHRP
Cash
27 Mar 15 09:31:05
RT @momotrader: In $GALE 1.37. Bottom chart, financing completed (51% higher at 2.08). Has sellers right now and needs to clear 1.40 for …
Trader News Daily
27 Mar 15 09:21:59
Wow http://t.co/PeRPkYu8Uk just posted last weeks results. +429%. Crazy. They offer a free trial too. $BSBR $ARIA $GALE $NBG $MHR
BM
27 Mar 15 09:00:53
$GALE Dbl bottom? On Watchlist https://t.co/vwc6yP5Vby
Cash
27 Mar 15 09:00:31
In $GALE 1.37
Breaking News Now
27 Mar 15 08:27:05
$GALE: MLV Reiterates Buy on Galena Biopharma Inc Following Enrollment ...: http://t.co/KWbLFmR8Q2
Smarter Analyst
27 Mar 15 08:24:45
$GALE MLV Reiterates Buy on Galena Biopharma Inc Following Enrollment Expansion of NeuVax Combo Phase 2b http://t.co/1TsQXqq61K
Ben Bankhead
27 Mar 15 08:14:42
Picked up $GALE at 1.37
momotrader
27 Mar 15 08:09:37
In $GALE 1.37. Bottom chart, financing completed (51% higher at 2.08). Has sellers right now and needs to clear 1.40 for momo. Stops 1.3.
PennyStocker
27 Mar 15 08:09:34
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $GALE $NTEK $AG $VIP
Breaking News Now
27 Mar 15 07:57:02
$SDRL $GALE: Eye Catching Stocks: SeaDrill Limited (NYSE:SDRL), Galena ...: http://t.co/GUzbs05iVI
Chet Stedman
27 Mar 15 07:35:27
@MoxReports cc: $GALE
ProTradersNews
27 Mar 15 07:06:03
$GALE $MRK: Why Need to Watch: McDonald's Corp. (NYSE:MCD), Aratana ...: http://t.co/48DxieAiHI
Bill Evancho
27 Mar 15 06:22:07
RT @StockDawgzz: Our Penny Stock Picks Have Gained Over 1485% In The Past 4 Months! MASSIVE Update: http://t.co/Nr8lmTigQP $ETEK $GALE $RSOL
Trader News Daily
27 Mar 15 06:18:32
Wow http://t.co/PeRPkYu8Uk just posted last weeks results. +429%. Crazy. They offer a free trial too. $BSBR $ARIA $GALE $NBG $MHR
Breaking News
27 Mar 15 05:04:04
$GALE: 4 High-Gross Margin Stocks: Galena Biopharma , (GALE ...: http://t.co/igiNlOYuSQ
Bill Evancho
27 Mar 15 04:07:54
@ACInvestorBlog What are your thoughts on $gale ? 52 wk low; dilution settled in; nice pipline. Average price target around $5.00.......
Stock Dawgzz
27 Mar 15 02:26:12
Our Penny Stock Picks Have Gained Over 1485% In The Past 4 Months! MASSIVE Update: http://t.co/Nr8lmTigQP $ETEK $GALE $RSOL
StockenheimerSchmidt
27 Mar 15 02:01:19
Our Penny Stock Pick On $THCZ Is Up 321.54% In Less Than 6 Weeks! This is Huge: http://t.co/WroUGtaeZF $ETEK $GALE $RSOL
Stockaholics
27 Mar 15 00:30:10
Our Winning Stock Tips Gained Over 680% In The Past 2 Months! Subscribe Today: http://t.co/lLjJU4COQW $ETEK $GALE $RSOL
zinvestmentz
26 Mar 15 19:58:59
$FWDG Next 2 Explode like $MDCN Medican Enterprises Zoning Approval Marijuana Ops 67K Sq Ft http://t.co/BgVr96s1v6 $CANN $GALE $SIRI $DVAX
Capital Market Labs
26 Mar 15 19:23:57
$GALE, $SPPI, $MDXG, $ENTA, $HPTX Cash from Operations Trend Comparison Chart: http://t.co/heARD23zK6
Penny Stockington
26 Mar 15 16:52:57
Our Penny Stock Pick On $THCZ Is Up 321.54% In Less Than 6 Weeks! Big News: http://t.co/PqlF5t9PRj $ETEK $GALE $RSOL
Stockaholics
26 Mar 15 15:38:58
Our Penny Stock Alerts Gained 600% In 2 Months! Get Our Next Picks Early: http://t.co/tEvkQFqi7N $ETEK $GALE $RSOL
StockenheimerSchmidt
26 Mar 15 15:04:32
Our Penny Stock Picks Have Gained Over 1485% In The Past 4 Months! MASSIVE Update: http://t.co/Cu9lMFFRwA $ETEK $GALE $RSOL
dailystockplays.com
26 Mar 15 14:39:45
NR7 http://t.co/JeVawk6mAq $AVP $ABBV $AIG $SLV $WU $CTL $TSN $STWD $GNW $ITB $SYY $YOKU $SXL $SPF $MON $TWC $NRG $KBH $TOL $GALE
Stock Rocket
26 Mar 15 13:53:53
$THCZ Has Become One Of The Hottest Penny Stocks Of The Year So Far! Check It Out: http://t.co/3wv3AMJ7Ni $ETEK $GALE $RSOL
Stock Dawgzz
26 Mar 15 13:06:57
Our Penny Stock Newsletter Alert On $RCGP Gained 57% Mid-Day Today! Blog Update: http://t.co/Dk7CzkVjdH $ETEK $GALE $RSOL
TrendCache
26 Mar 15 12:34:54
Trending #Biotech topics include $GALE, $AAPL, #Uthscsa #stocks #invest See more http://t.co/EpbbdqDEG1
PennyStocker
26 Mar 15 12:24:45
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $GALE $NTEK $AG $VIP
Justin St Julien
26 Mar 15 12:16:58
$gale $fcel $cpst
Seeking Alpha Alerts
26 Mar 15 10:55:13
@DallasStockGeek $GALE Galena expands patient population in NeuVax breast cancer trial http://t.co/n4QIQxNXw2
Trader News Daily
26 Mar 15 10:48:27
Wow http://t.co/PeRPkYu8Uk just posted last weeks results. +429%. Crazy. They offer a free trial too. $BSBR $ARIA $GALE $NBG $MHR
FinPsychDrew
26 Mar 15 09:19:06
$GALE back to what was paid, considering adding more.
DJ Olive
26 Mar 15 09:15:27
RT @MarketCurrents: Galena expands patient population in NeuVax breast cancer trial http://t.co/L8pwTSIZmI $GALE
				
				
By  +Follow February 14, 2014 5:26AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.